<li>alfentanil<p>cyclosporine will increase the level or effect of alfentanil by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>alfuzosin<p>cyclosporine will increase the level or effect of alfuzosin by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>allopurinol<p>allopurinol increases levels of cyclosporine by unknown mechanism. Minor/Significance Unknown.</p></li><li>alosetron<p>cyclosporine will increase the level or effect of alosetron by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>alprostadil intracavernous/urethral<p>alprostadil intracavernous/urethral decreases effects of cyclosporine by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>alvimopan<p>cyclosporine will increase the level or effect of alvimopan by  P-glycoprotein (MDR1) efflux transporter. Minor/Significance Unknown.</p></li><li>amiodarone<p>amiodarone increases levels of cyclosporine by decreasing renal clearance. Minor/Significance Unknown.</p></li><li>amlodipine<p>cyclosporine will increase the level or effect of amlodipine by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>anidulafungin<p>cyclosporine increases levels of anidulafungin by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>armodafinil<p>cyclosporine will increase the level or effect of armodafinil by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.<span><br><br></span>cyclosporine will increase the level or effect of armodafinil by  P-glycoprotein (MDR1) efflux transporter. Minor/Significance Unknown.</p></li><li>atazanavir<p>cyclosporine will increase the level or effect of atazanavir by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>budesonide<p>budesonide, cyclosporine.
Either increases levels of the other by decreasing metabolism. Minor/Significance Unknown.</p></li><li>bupropion<p>bupropion decreases levels of cyclosporine by unknown mechanism. Minor/Significance Unknown. Case report only.</p></li><li>cevimeline<p>cyclosporine will increase the level or effect of cevimeline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>chlorpropamide<p>chlorpropamide increases levels of cyclosporine by unknown mechanism. Minor/Significance Unknown.</p></li><li>cisapride<p>cisapride, cyclosporine.
Either increases levels of the other by decreasing metabolism. Minor/Significance Unknown.</p></li><li>clarithromycin<p>cyclosporine will increase the level or effect of clarithromycin by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>clobetasone<p>clobetasone, cyclosporine.
Either increases levels of the other by decreasing metabolism. Minor/Significance Unknown.</p></li><li>clomethiazole<p>cyclosporine will increase the level or effect of clomethiazole by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>clonidine<p>clonidine increases levels of cyclosporine by unknown mechanism. Minor/Significance Unknown.</p></li><li>clotrimazole<p>clotrimazole increases levels of cyclosporine by decreasing metabolism. Minor/Significance Unknown.</p></li><li>cordyceps<p>cordyceps decreases toxicity of cyclosporine by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>cortisone<p>cortisone, cyclosporine.
Either increases levels of the other by decreasing metabolism. Minor/Significance Unknown.</p></li><li>creatine<p>creatine, cyclosporine. Mechanism: pharmacodynamic synergism. Minor/Significance Unknown. (Theoretical interaction) Combination may have additive nephrotoxic effects.</p></li><li>dapsone<p>cyclosporine will increase the level or effect of dapsone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>deflazacort<p>deflazacort, cyclosporine.
Either increases levels of the other by decreasing metabolism. Minor/Significance Unknown.</p></li><li>delavirdine<p>cyclosporine will increase the level or effect of delavirdine by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>dexamethasone<p>dexamethasone, cyclosporine.
Either increases levels of the other by decreasing metabolism. Minor/Significance Unknown.</p></li><li>disopyramide<p>cyclosporine will increase the level or effect of disopyramide by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>docetaxel<p>cyclosporine will increase the level or effect of docetaxel by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>donepezil<p>cyclosporine will increase the level or effect of donepezil by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>drospirenone<p>drospirenone, cyclosporine. Mechanism: pharmacodynamic synergism. Minor/Significance Unknown. Hyperkalemia.</p></li><li>dutasteride<p>cyclosporine will increase the level or effect of dutasteride by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>efavirenz<p>cyclosporine will increase the level or effect of efavirenz by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>enalapril<p>cyclosporine will increase the level or effect of enalapril by  Other (see comment). Minor/Significance Unknown. may increase plasma concentrations of OATP substrates</p></li><li>eplerenone<p>cyclosporine will increase the level or effect of eplerenone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>epoetin beta<p>epoetin beta, cyclosporine. Other (see comment). Minor/Significance Unknown. 
Comment: Since cyclosporine is bound by RBCs, monitor levels and adjust dose as hematocrit rises.</p></li><li>epoetin delta<p>epoetin delta, cyclosporine. Other (see comment). Minor/Significance Unknown. 
Comment: Since cyclosporine is bound by RBCs, monitor levels and adjust dose as hematocrit rises.</p></li><li>epoetin zeta<p>epoetin zeta, cyclosporine. Other (see comment). Minor/Significance Unknown. 
Comment: Since cyclosporine is bound by RBCs, monitor levels and adjust dose as hematocrit rises.</p></li><li>esomeprazole<p>cyclosporine, esomeprazole. Other (see comment). Minor/Significance Unknown. 
Comment: Effectiveness of proton pump inhibitors may be decreased theoretically if administered with other antisecretory agents.</p></li><li>etoricoxib<p>cyclosporine will increase the level or effect of etoricoxib by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>eucalyptus<p>cyclosporine will increase the level or effect of eucalyptus by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>fenofibrate<p>fenofibrate increases levels of cyclosporine by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>fenofibrate micronized<p>fenofibrate micronized increases levels of cyclosporine by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>fenofibric acid<p>fenofibric acid increases levels of cyclosporine by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>fexofenadine<p>cyclosporine will increase the level or effect of fexofenadine by  P-glycoprotein (MDR1) efflux transporter. Minor/Significance Unknown.</p></li><li>finasteride<p>cyclosporine will increase the level or effect of finasteride by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>fludrocortisone<p>fludrocortisone, cyclosporine.
Either increases levels of the other by decreasing metabolism. Minor/Significance Unknown.</p></li><li>galantamine<p>cyclosporine will increase the level or effect of galantamine by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>glimepiride<p>glimepiride increases levels of cyclosporine by unknown mechanism. Minor/Significance Unknown.</p></li><li>glipizide<p>glipizide increases levels of cyclosporine by unknown mechanism. Minor/Significance Unknown.</p></li><li>gliquidone<p>gliquidone increases levels of cyclosporine by unknown mechanism. Minor/Significance Unknown.</p></li><li>glyburide<p>glyburide increases levels of cyclosporine by unknown mechanism. Minor/Significance Unknown.</p></li><li>griseofulvin<p>griseofulvin increases levels of cyclosporine by unknown mechanism. Minor/Significance Unknown.</p></li><li>hydrocortisone<p>hydrocortisone, cyclosporine.
Either increases levels of the other by decreasing metabolism. Minor/Significance Unknown.</p></li><li>imatinib<p>cyclosporine will increase the level or effect of imatinib by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>imipenem/cilastatin<p>cyclosporine, imipenem/cilastatin. Mechanism: pharmacodynamic synergism. Minor/Significance Unknown. Risk of CNS toxicity.</p></li><li>isradipine<p>cyclosporine will increase the level or effect of isradipine by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>itraconazole<p>cyclosporine will increase the level or effect of itraconazole by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>ketoconazole<p>cyclosporine will increase the level or effect of ketoconazole by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>levofloxacin<p>cyclosporine will increase the level or effect of levofloxacin by  Other (see comment). Minor/Significance Unknown. may increase plasma concentrations of organic anion transporter protein substrates</p></li><li>loratadine<p>cyclosporine will increase the level or effect of loratadine by  P-glycoprotein (MDR1) efflux transporter. Minor/Significance Unknown.</p></li><li>magnesium chloride<p>cyclosporine decreases levels of magnesium chloride by increasing renal clearance. Minor/Significance Unknown.</p></li><li>magnesium citrate<p>cyclosporine decreases levels of magnesium citrate by increasing renal clearance. Minor/Significance Unknown.</p></li><li>magnesium hydroxide<p>cyclosporine decreases levels of magnesium hydroxide by increasing renal clearance. Minor/Significance Unknown.</p></li><li>magnesium oxide<p>cyclosporine decreases levels of magnesium oxide by increasing renal clearance. Minor/Significance Unknown.</p></li><li>magnesium sulfate<p>cyclosporine decreases levels of magnesium sulfate by increasing renal clearance. Minor/Significance Unknown.</p></li><li>mestranol<p>mestranol increases levels of cyclosporine by unknown mechanism. Minor/Significance Unknown.</p></li><li>methylprednisolone<p>methylprednisolone, cyclosporine.
Either increases levels of the other by decreasing metabolism. Minor/Significance Unknown.</p></li><li>mibefradil<p>cyclosporine will increase the level or effect of mibefradil by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>montelukast<p>cyclosporine will increase the level or effect of montelukast by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>nifedipine<p>cyclosporine will increase the level or effect of nifedipine by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>nimodipine<p>cyclosporine will increase the level or effect of nimodipine by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>nitrendipine<p>cyclosporine will increase the level or effect of nitrendipine by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>omeprazole<p>cyclosporine, omeprazole.
Either increases toxicity of the other by Other (see comment). Minor/Significance Unknown. 
Comment: Effectiveness of proton pump inhibitors may be decreased theoretically if administered with other antisecretory agents.</p></li><li>oxybutynin<p>cyclosporine will increase the level or effect of oxybutynin by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>paclitaxel<p>cyclosporine will increase the level or effect of paclitaxel by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>paclitaxel protein bound<p>cyclosporine will increase the level or effect of paclitaxel protein bound by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>parecoxib<p>cyclosporine will increase the level or effect of parecoxib by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>pimozide<p>cyclosporine will increase the level or effect of pimozide by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>pioglitazone<p>cyclosporine will increase the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>prednisolone<p>prednisolone, cyclosporine.
Either increases levels of the other by decreasing metabolism. Minor/Significance Unknown.</p></li><li>prednisone<p>prednisone, cyclosporine.
Either increases levels of the other by decreasing metabolism. Minor/Significance Unknown.</p></li><li>propafenone<p>cyclosporine will increase the level or effect of propafenone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>pyrazinamide<p>pyrazinamide decreases levels of cyclosporine by unknown mechanism. Minor/Significance Unknown.</p></li><li>quinine<p>cyclosporine will increase the level or effect of quinine by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>ramelteon<p>cyclosporine will increase the level or effect of ramelteon by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>roxithromycin<p>cyclosporine increases levels of roxithromycin by decreasing elimination. Minor/Significance Unknown.</p></li><li>saxagliptin<p>cyclosporine will increase the level or effect of saxagliptin by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>sufentanil<p>cyclosporine will increase the level or effect of sufentanil by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>telithromycin<p>cyclosporine will increase the level or effect of telithromycin by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>ticlopidine<p>ticlopidine decreases levels of cyclosporine by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>tolazamide<p>tolazamide increases levels of cyclosporine by unknown mechanism. Minor/Significance Unknown.</p></li><li>tolbutamide<p>tolbutamide increases levels of cyclosporine by unknown mechanism. Minor/Significance Unknown.</p></li><li>triamcinolone<p>triamcinolone, cyclosporine.
Either increases levels of the other by decreasing metabolism. Minor/Significance Unknown.</p></li><li>troleandomycin<p>cyclosporine will increase the level or effect of troleandomycin by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>vesnarinone<p>cyclosporine will increase the level or effect of vesnarinone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>vinblastine<p>cyclosporine will increase the level or effect of vinblastine by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>vincristine<p>cyclosporine will increase the level or effect of vincristine by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>vincristine liposomal<p>cyclosporine will increase the level or effect of vincristine liposomal by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>vinorelbine<p>cyclosporine will increase the level or effect of vinorelbine by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>zaleplon<p>cyclosporine will increase the level or effect of zaleplon by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>ziprasidone<p>cyclosporine will increase the level or effect of ziprasidone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>zolpidem<p>cyclosporine will increase the level or effect of zolpidem by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>zonisamide<p>cyclosporine will increase the level or effect of zonisamide by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li>